Literature DB >> 29024550

Biology of obesity and weight regain: Implications for clinical practice.

Mary Madeline Rogge1, Bibha Gautam1.   

Abstract

BACKGROUND AND
PURPOSE: Weight loss is recommended as first-line therapy for many chronic illnesses, including obesity. Most patients who do successfully lose weight are unable to maintain their reduced weight. Recent research findings are reviewed and synthesized to explain the biology of obesity, adaptation to weight loss, and weight regain.
FINDINGS: Weight regain is a common consequence of successful weight loss. Current obesity management strategies fail to take into consideration the underlying genetic and environmental causes of obesity. Available treatment modalities create a negative energy balance that stimulates integrated, persistent neurologic, endocrine, muscle, and adipose tissue adaptation to restore body weight and fat mass, independent of lifestyle changes. IMPLICATIONS FOR PRACTICE: Understanding the pathophysiology of obesity and weight loss alters nurse practitioners' responsibilities in caring for patients with obesity. They are responsible for expanding assessment and intervention strategies and offering people with obesity realistic expectations for weight loss and regain. They are obligated to explain weight regain when it occurs to minimize patient frustration. Nurse practitioners have the opportunity to adopt new approaches to patient advocacy, especially in the areas of public policy to improve diagnostic tools and adjunctive therapy for people with obesity. ©2017 American Association of Nurse Practitioners.

Entities:  

Keywords:  Adipogenesis; obesity pathophysiology; obesity recidivism; obesity relapse; weight regain

Mesh:

Year:  2017        PMID: 29024550     DOI: 10.1002/2327-6924.12504

Source DB:  PubMed          Journal:  J Am Assoc Nurse Pract        ISSN: 2327-6886            Impact factor:   1.165


  2 in total

Review 1.  Obesity: Risk factors, complications, and strategies for sustainable long-term weight management.

Authors:  Sharon M Fruh
Journal:  J Am Assoc Nurse Pract       Date:  2017-10       Impact factor: 1.495

2.  KLHL3 deficiency in mice ameliorates obesity, insulin resistance, and nonalcoholic fatty liver disease by regulating energy expenditure.

Authors:  Ju-Hong Jang; Jeong Woong Lee; Min Ji Cho; Byungtae Hwang; Min-Gi Kwon; Dong-Hwan Kim; Nam-Kyung Lee; Jangwook Lee; Young-Jun Park; Yong Ryoul Yang; Jinchul Kim; Yong-Hoon Kim; Tae Hyeon An; Kyoung-Jin Oh; Kwang-Hee Bae; Jong-Gil Park; Jeong-Ki Min
Journal:  Exp Mol Med       Date:  2022-08-26       Impact factor: 12.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.